G. Verbruggen

729 total citations
26 papers, 521 citations indexed

About

G. Verbruggen is a scholar working on Rheumatology, Surgery and Cell Biology. According to data from OpenAlex, G. Verbruggen has authored 26 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 7 papers in Surgery and 7 papers in Cell Biology. Recurrent topics in G. Verbruggen's work include Osteoarthritis Treatment and Mechanisms (14 papers), Proteoglycans and glycosaminoglycans research (6 papers) and Inflammatory mediators and NSAID effects (4 papers). G. Verbruggen is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (14 papers), Proteoglycans and glycosaminoglycans research (6 papers) and Inflammatory mediators and NSAID effects (4 papers). G. Verbruggen collaborates with scholars based in Belgium and France. G. Verbruggen's co-authors include E M Veys, Stefan Goemaere, Dirk Elewaut, Peter Verdonk, Herman Mielants, K. Schelstraete, Stijn Lambrecht, Karl Almqvist, Dieter Deforce and Frank P. Luyten and has published in prestigious journals such as Gastroenterology, Analytical Biochemistry and Clinical Chemistry.

In The Last Decade

G. Verbruggen

26 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Verbruggen Belgium 11 343 125 102 96 90 26 521
Joseph Quintavalla United States 9 162 0.5× 153 1.2× 34 0.3× 113 1.2× 93 1.0× 11 497
S Macháček Czechia 3 606 1.8× 323 2.6× 82 0.8× 79 0.8× 188 2.1× 5 720
Marie-Thérèse Corvol France 11 208 0.6× 72 0.6× 72 0.7× 235 2.4× 35 0.4× 18 588
Wenfeng Xiao China 13 344 1.0× 109 0.9× 49 0.5× 222 2.3× 95 1.1× 25 622
Johanne Martel‐Pelletier Canada 11 381 1.1× 245 2.0× 36 0.4× 257 2.7× 67 0.7× 12 614
Marcia L. Bliven United States 11 210 0.6× 127 1.0× 14 0.1× 72 0.8× 122 1.4× 28 459
M. Lires-Deán Spain 6 302 0.9× 120 1.0× 28 0.3× 192 2.0× 41 0.5× 8 488
Johanne Martel-Pelletier Canada 5 296 0.9× 143 1.1× 19 0.2× 124 1.3× 73 0.8× 7 423
F C Jolicoeur Canada 9 234 0.7× 174 1.4× 16 0.2× 93 1.0× 59 0.7× 9 527
Sabrina Priam France 7 175 0.5× 85 0.7× 46 0.5× 190 2.0× 36 0.4× 13 458

Countries citing papers authored by G. Verbruggen

Since Specialization
Citations

This map shows the geographic impact of G. Verbruggen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Verbruggen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Verbruggen more than expected).

Fields of papers citing papers by G. Verbruggen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Verbruggen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Verbruggen. The network helps show where G. Verbruggen may publish in the future.

Co-authorship network of co-authors of G. Verbruggen

This figure shows the co-authorship network connecting the top 25 collaborators of G. Verbruggen. A scholar is included among the top collaborators of G. Verbruggen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Verbruggen. G. Verbruggen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lambrecht, Stijn, Aad Dhollander, Peggy Jacques, et al.. (2011). Optimized alkylated cyclodextrin polysulphates with reduced risks on thromboembolic accidents improve osteoarthritic chondrocyte metabolism. Lara D. Veeken. 50(7). 1226–1235. 6 indexed citations
2.
Wittoek, Ruth & G. Verbruggen. (2008). 251 CORRELATION BETWEEN FIHOA AND AUSCAN AND RADIOGRAPHIC DAMAGE IN PATIENTS WITH OSTEOARTHRITIS OF THE HANDS. Osteoarthritis and Cartilage. 16. S114–S114. 1 indexed citations
3.
Lambrecht, Stijn, G. Verbruggen, Peter Verdonk, Dirk Elewaut, & Dieter Deforce. (2007). Differential proteome analysis of normal and osteoarthritic chondrocytes reveals distortion of vimentin network in osteoarthritis. Osteoarthritis and Cartilage. 16(2). 163–173. 65 indexed citations
4.
Verbruggen, G.. (2005). Chondroprotective drugs in degenerative joint diseases. Lara D. Veeken. 45(2). 129–138. 117 indexed citations
5.
Verdonk, Peter, et al.. (2003). Homeostasis of the extracellular matrix of normal and osteoarthritic human articular cartilage chondrocytes in vitro. Osteoarthritis and Cartilage. 11(11). 801–809. 55 indexed citations
6.
7.
Almqvist, Karl, et al.. (2001). Evaluation of chondrocyte cell-associated matrix metabolism by flow cytometry. Osteoarthritis and Cartilage. 9(5). 454–462. 14 indexed citations
8.
Verbruggen, G., et al.. (1998). Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA. Osteoarthritis and Cartilage. 6. 37–38. 79 indexed citations
9.
Verbruggen, G., et al.. (1993). Influence of interferon-gamma on isolated chondrocytes from human articular cartilage. Dose dependent inhibition of cell proliferation and proteoglycan synthesis.. PubMed. 20(6). 1020–6. 11 indexed citations
10.
Verbruggen, G., Anne‐Marie Malfait, Karl Almqvist, et al.. (1993). Development of Immortalized Human Articular Cartilage Cell Lines. Birkhäuser Basel eBooks. 39. 267–272. 1 indexed citations
11.
Verbruggen, G., et al.. (1991). Influence of human recombinant interleukin-1 beta on human articular cartilage. Mitotic activity and proteoglycan metabolism.. PubMed. 9(5). 481–8. 5 indexed citations
12.
Verbruggen, G., et al.. (1990). Proteoglycan metabolism in isolated chondrocytes from human cartilage. Influence of niflumic acid. Clinical Rheumatology. 9(1). 32–41. 3 indexed citations
13.
Verbruggen, G., et al.. (1990). The synthesis and immobilisation of cartilage-specific proteoglycan by human chondrocytes in different concentrations of agarose.. PubMed. 8(4). 371–8. 23 indexed citations
14.
Keyser, Filip De, et al.. (1989). Microgel immunoblotting of thymus and nuclear extracts by unidirectional diffusion. Analytical Biochemistry. 176(2). 350–352. 1 indexed citations
15.
Luyten, Frank P., et al.. (1987). In vitro repair potential of articular cartilage: proteoglycan metabolism in the different areas of the femoral condyles in human cartilage explants.. PubMed. 14(2). 329–34. 6 indexed citations
16.
Mielants, Herman, et al.. (1987). Disease manifestations of progressive systemic sclerosis: sensitivity and specificity. Clinical Rheumatology. 6(4). 532–538. 8 indexed citations
17.
Luyten, Frank P., G. Verbruggen, & Eric Veys. (1987). Reparative response of human articular cartilage in tissue culture. Comparison between a normal and an osteoarthritic knee of the same donor.. PubMed. 5(2). 103–10. 3 indexed citations
18.
Verbruggen, G., Frank P. Luyten, & E M Veys. (1985). Repair function in organ cultured human cartilage. Replacement of enzymatically removed proteoglycans during longterm organ culture.. PubMed. 12(4). 665–74. 13 indexed citations
19.
Mielants, Herman, E M Veys, G. Verbruggen, & K. Schelstraete. (1984). Salicylate-induced occult gastrointestinal blood loss: comparison between different oral and parenteral forms of acetylsalicylates and salicylates. Clinical Rheumatology. 3(1). 47–54. 3 indexed citations
20.
Mielants, Herman, E M Veys, G. Verbruggen, & K. Schelstraete. (1981). Comparison of Serum Salicylate Levels and Gastro-Intestinal Blood Loss Between Salsalate (Disalcid) and other Forms of Salicylates. Scandinavian Journal of Rheumatology. 10(3). 169–173. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph Quintavalla Breakdown of academic impact, for papers by S Macháček Breakdown of academic impact, for papers by Marie-Thérèse Corvol Breakdown of academic impact, for papers by Wenfeng Xiao Breakdown of academic impact, for papers by Johanne Martel‐Pelletier Breakdown of academic impact, for papers by Marcia L. Bliven Breakdown of academic impact, for papers by M. Lires-Deán Breakdown of academic impact, for papers by Johanne Martel-Pelletier Breakdown of academic impact, for papers by F C Jolicoeur Breakdown of academic impact, for papers by Sabrina Priam
Rankless by CCL
2026